EE03765B1 - Propioonhappe derivaadid ja nende kasutamine - Google Patents
Propioonhappe derivaadid ja nende kasutamineInfo
- Publication number
- EE03765B1 EE03765B1 EEP199900069A EE9900069A EE03765B1 EE 03765 B1 EE03765 B1 EE 03765B1 EE P199900069 A EEP199900069 A EE P199900069A EE 9900069 A EE9900069 A EE 9900069A EE 03765 B1 EE03765 B1 EE 03765B1
- Authority
- EE
- Estonia
- Prior art keywords
- propionic acid
- acid derivatives
- derivatives
- propionic
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21754896A JP3215048B2 (ja) | 1996-04-03 | 1996-08-19 | プロピオン酸誘導体及びその用途 |
| PCT/JP1997/002873 WO1998007699A1 (fr) | 1996-08-19 | 1997-08-19 | Derives d'acide propionique et applications de ces derives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9900069A EE9900069A (et) | 1999-10-15 |
| EE03765B1 true EE03765B1 (et) | 2002-06-17 |
Family
ID=16705991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900069A EE03765B1 (et) | 1996-08-19 | 1997-08-19 | Propioonhappe derivaadid ja nende kasutamine |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6204277B1 (et) |
| EP (1) | EP0930299A1 (et) |
| KR (1) | KR20000068151A (et) |
| CN (1) | CN1233241A (et) |
| AU (1) | AU740444B2 (et) |
| BG (1) | BG103268A (et) |
| BR (1) | BR9711627A (et) |
| CA (1) | CA2263721A1 (et) |
| CZ (1) | CZ53699A3 (et) |
| EE (1) | EE03765B1 (et) |
| IL (1) | IL128600A0 (et) |
| NO (1) | NO312160B1 (et) |
| NZ (1) | NZ334738A (et) |
| PL (1) | PL331861A1 (et) |
| RU (1) | RU2174121C2 (et) |
| SK (1) | SK21099A3 (et) |
| WO (1) | WO1998007699A1 (et) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL121202A (en) | 1996-07-01 | 2001-08-26 | Lilly Co Eli | Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof |
| AU749132B2 (en) | 1997-08-28 | 2002-06-20 | Biovitrum Ab | Inhibitors of protein tyrosine phosphatase |
| US6410585B1 (en) * | 1997-08-28 | 2002-06-25 | Scott D. Larsen | Inhibitors of protein tyrosine phosphatase |
| JP4345230B2 (ja) | 1998-03-10 | 2009-10-14 | 小野薬品工業株式会社 | カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤 |
| GB9817118D0 (en) * | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| WO2000037422A2 (en) * | 1998-12-22 | 2000-06-29 | Neurosearch A/S | Ion channel modulating agents |
| GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| US6417212B1 (en) | 1999-08-27 | 2002-07-09 | Eli Lilly & Company | Modulators of peroxisome proliferator activated receptors |
| JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
| US6958355B2 (en) | 2000-04-24 | 2005-10-25 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US7049342B2 (en) | 2000-05-29 | 2006-05-23 | Kyorin Pharmaceutical Co., Ltd. | Substituted phenylpropionic acid derivatives |
| DE60135742D1 (de) * | 2000-05-29 | 2008-10-23 | Kyorin Seiyaku Kk | Substituierte phenylpropionsäure-derivate |
| US6525095B1 (en) * | 2000-07-10 | 2003-02-25 | New Mexico State University Technology Transfer Corporation | Propionate feed supplement |
| EP1313717B1 (en) | 2000-08-23 | 2007-10-17 | Eli Lilly And Company | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| CA2420178A1 (en) | 2000-08-23 | 2002-03-07 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
| DE60128239T2 (de) * | 2000-08-23 | 2008-01-10 | Eli Lilly And Co., Indianapolis | Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten |
| WO2002024689A1 (en) | 2000-09-21 | 2002-03-28 | Aryx Therapeutics | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis |
| GB0031109D0 (en) | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| GB0113231D0 (en) | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
| KR100474137B1 (ko) * | 2001-11-16 | 2005-03-08 | (주)바이오뉴트리젠 | 신규의 아릴프로피온산 유도체 및 이를 포함하는 당뇨병 예방 또는 치료용 조성물 |
| KR100459917B1 (ko) * | 2001-12-14 | 2004-12-03 | (주)바이오뉴트리젠 | 페놀릭산 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물 |
| ITRM20020016A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza |
| WO2003059895A1 (fr) * | 2002-01-17 | 2003-07-24 | Toaeiyo Ltd. | Derives d'acide halogenobenzylaminopropionique |
| WO2003062427A1 (fr) * | 2002-01-23 | 2003-07-31 | Yamanouchi Pharmaceutical Co., Ltd. | Methode de criblage de medicaments ameliorant la resistance a l'insuline |
| WO2003072102A1 (en) | 2002-02-25 | 2003-09-04 | Eli Lilly And Company | Peroxisome proliferator activated receptor modulators |
| DE60315603T2 (de) | 2002-02-25 | 2008-05-21 | Eli Lilly And Co., Indianapolis | Modulatoren von peroxisome proliferator-aktivierten rezeptoren |
| US6833380B2 (en) | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
| US20030207924A1 (en) * | 2002-03-07 | 2003-11-06 | Xue-Min Cheng | Compounds that modulate PPAR activity and methods of preparation |
| US6716842B2 (en) | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
| US6875780B2 (en) | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
| KR100474202B1 (ko) * | 2002-05-04 | 2005-03-08 | 강헌중 | 티아졸 유도체의 제조방법 및 이를 제조하기 위한 중간체 |
| EP1569916B1 (en) * | 2002-11-15 | 2009-01-07 | Cadila Healthcare Ltd. | Substituted aralkyl derivatives |
| US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| US7037384B2 (en) * | 2003-06-23 | 2006-05-02 | Bulk Chemicals, Inc. | Lubricating chemical coating for metalworking |
| CN100436430C (zh) * | 2004-05-24 | 2008-11-26 | 北京摩力克科技有限公司 | 作为hPPARα和hPPARγ激动剂的烷酰基取代的酪氨酸衍生物 |
| BRPI0515015A (pt) * | 2004-08-11 | 2008-07-01 | Kyorin Seiyaku Kk | derivado cìclico de ácido aminobenzóico; medicamento; agonista ppar(alpha); agonista duplo ppar(alpha), y; agonista duplo ppar(alpha), (delta); modulador ppar; agente lipìdeo; agente profilático ou terapêutico compreendendo pelo menos um dos derivados cìclicos de ácido aminobenzóico ou sal do mesmo farmacêuticamente aceitável |
| FR2882359A1 (fr) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | Derives activateurs de ppar, procede de preparation et application en therapeutique |
| FR2901792A1 (fr) * | 2006-06-06 | 2007-12-07 | Negma Lerads Soc Par Actions S | DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE |
| KR101497577B1 (ko) * | 2012-07-31 | 2015-03-02 | 서울대학교산학협력단 | 2-에톡시프로피온산 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 일주기 연관성 질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| CA2087437A1 (en) | 1990-08-23 | 1992-02-24 | Steven W. Goldstein | Hypoglycemic hydroxyurea derivatives |
| US5498621A (en) | 1992-05-01 | 1996-03-12 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
| GB9225386D0 (en) * | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| TW268952B (et) | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
| US5591862A (en) | 1993-06-11 | 1997-01-07 | Takeda Chemical Industries, Ltd. | Tetrazole derivatives, their production and use |
| JP3466273B2 (ja) * | 1993-06-11 | 2003-11-10 | 武田薬品工業株式会社 | テトラゾール誘導体、その製造法およびそれを含んでなる医薬 |
| CA2157032C (en) | 1993-12-27 | 1999-09-28 | Hisashi Shinkai | Isoxazolidinedione derivative and use thereof |
| JPH08325263A (ja) | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規２−アミノ−３−フェニルプロピオン酸誘導体 |
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| IL121202A (en) | 1996-07-01 | 2001-08-26 | Lilly Co Eli | Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof |
-
1997
- 1997-08-19 RU RU99105567/04A patent/RU2174121C2/ru not_active IP Right Cessation
- 1997-08-19 CA CA002263721A patent/CA2263721A1/en not_active Abandoned
- 1997-08-19 EE EEP199900069A patent/EE03765B1/et not_active IP Right Cessation
- 1997-08-19 AU AU38665/97A patent/AU740444B2/en not_active Ceased
- 1997-08-19 BR BR9711627A patent/BR9711627A/pt unknown
- 1997-08-19 SK SK210-99A patent/SK21099A3/sk unknown
- 1997-08-19 US US09/242,620 patent/US6204277B1/en not_active Expired - Fee Related
- 1997-08-19 KR KR1019997001230A patent/KR20000068151A/ko not_active Application Discontinuation
- 1997-08-19 CN CN97198837A patent/CN1233241A/zh active Pending
- 1997-08-19 NZ NZ334738A patent/NZ334738A/xx unknown
- 1997-08-19 PL PL97331861A patent/PL331861A1/xx unknown
- 1997-08-19 IL IL12860097A patent/IL128600A0/xx unknown
- 1997-08-19 CZ CZ99536A patent/CZ53699A3/cs unknown
- 1997-08-19 WO PCT/JP1997/002873 patent/WO1998007699A1/ja not_active Application Discontinuation
- 1997-08-19 EP EP97935823A patent/EP0930299A1/en not_active Withdrawn
-
1999
- 1999-02-15 NO NO19990700A patent/NO312160B1/no unknown
- 1999-03-18 BG BG103268A patent/BG103268A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3866597A (en) | 1998-03-06 |
| KR20000068151A (ko) | 2000-11-25 |
| RU2174121C2 (ru) | 2001-09-27 |
| AU740444B2 (en) | 2001-11-01 |
| PL331861A1 (en) | 1999-08-16 |
| IL128600A0 (en) | 2000-01-31 |
| BR9711627A (pt) | 1999-08-24 |
| EP0930299A4 (et) | 1999-07-21 |
| NO990700L (no) | 1999-04-19 |
| US6204277B1 (en) | 2001-03-20 |
| BG103268A (en) | 2000-12-29 |
| EP0930299A1 (en) | 1999-07-21 |
| NZ334738A (en) | 2001-01-26 |
| NO312160B1 (no) | 2002-04-02 |
| SK21099A3 (en) | 2000-05-16 |
| NO990700D0 (no) | 1999-02-15 |
| WO1998007699A1 (fr) | 1998-02-26 |
| CA2263721A1 (en) | 1998-02-26 |
| CZ53699A3 (cs) | 1999-07-14 |
| CN1233241A (zh) | 1999-10-27 |
| EE9900069A (et) | 1999-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03765B1 (et) | Propioonhappe derivaadid ja nende kasutamine | |
| ATE237580T1 (de) | 5-alkyl-2-arylaminophenylessigsäure und derivative | |
| DE69703385D1 (de) | Alkoxyessigsäure-derivate | |
| NO990821D0 (no) | Arylsulfonylamino-hydroksaminsyre-derivater | |
| FI961599A (fi) | 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia | |
| ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
| FI953479A0 (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
| NO924978L (no) | Chinolon- og naftyridon-karboksylsyrederivater | |
| ATE248812T1 (de) | Arylsulfonylhydroxamsäurederivate | |
| DK1003720T3 (da) | Aryloxyarylsulfonylaminohydroxamsyrederivater | |
| FI941137A (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
| EP1024130A4 (en) | BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE | |
| NO922291D0 (no) | 7-azaisoindolinyl-kinolon- og naftyridonkarboksylsyrederivater | |
| FI940216A0 (fi) | Kinoloni- ja naftyridonikarboksyylihappojohdannaiset | |
| FI951773A0 (fi) | Alfa-animoalkaanihapot ja niiden pelkistymistuotteet | |
| AU4161797A (en) | Benzoperimidine-carboxylic acids and derivatives thereof | |
| PT878467E (pt) | Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos | |
| ATE230734T1 (de) | 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate | |
| DE59707658D1 (de) | Glyoxylsäure-derivate | |
| AU6120298A (en) | 2-peperazinone-1-acetic acid derivatives and their use | |
| FI971085A0 (fi) | Uusia PKA:ta sitovia proteiineja ja näiden käyttömuotoja | |
| NO981002L (no) | Karboksylsyrederivater, deres fremstilling og anvendelse | |
| EE04061B1 (et) | Metüleenbisfosfoonhappe derivaadid | |
| NO930947L (no) | Cykloalkyl- og heterocyklylsubstituerte imidazolylpropensyrederivate | |
| FI941082A0 (fi) | Kinolonikarboksyylihappojohdannaiset, niiden valmistus ja käyttö |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20030819 |